KTTA Gains 153.39%
Tue, Nov 23, 2021 at 05:30 PM
KTTA (KTTA:NASDAQ) shot up at $5.6, a gain of 153.4%. On Mon, Nov 22, 2021, KTTA:NASDAQ hit a New 2-Week Low of $2.21. The stock got featured on our News Catalysts scanner on Tue, Nov 23, 2021 at 12:34 PM in the 'MISCELLANEOUS' category. From Mon, Nov 08, 2021, the stock recorded 40.00% Up Days and 36.36% Green Days
The stock spiked on Wed, Oct 27, 2021 at $4 with a volume of 8M+.
About KTTA (KTTA:NASDAQ)
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders.
Top 10 Gainers:
- Aptevo Therapeutics Inc. (APVO:NASDAQ), 162.81%
- KTTA (KTTA:NASDAQ), 153.39%
- QLGN (QLGN:NASDAQ), 104.8%
- VLON (VLON:NASDAQ), 81.59%
- PTPI (PTPI:NASDAQ), 75.94%
- ISPC (ISPC:NASDAQ), 48.54%
- MediciNova, Inc. (MNOV:NASDAQ), 43.97%
- VOSO (VOSO:NASDAQ), 43.95%
- CRXT (CRXT:NASDAQ), 42.96%
- Esperion Therapeutics, Inc. (ESPR:NASDAQ), 40.73%